850MO Phase II randomized trial of chemotherapy followed by surgery and PORT versus surgery and PORT for organ preservation of T3 and T4a (selected T4b) sinonasal squamous cell carcinoma (SNC): A trial of the ECOG-ACRIN cancer research group (EA3163)
Saba N, Flamand Y, Lin D, Chung C, McDonald M, Flampouri S, Khan S, Snyderman C, Hanna E, El-Sayed Y, Solares C, Duan F, Ho A, Samuels M, Swiecicki P, Subramaniam R, Chakravarthy A, Burtness B. 850MO Phase II randomized trial of chemotherapy followed by surgery and PORT versus surgery and PORT for organ preservation of T3 and T4a (selected T4b) sinonasal squamous cell carcinoma (SNC): A trial of the ECOG-ACRIN cancer research group (EA3163). Annals Of Oncology 2024, 35: s614. DOI: 10.1016/j.annonc.2024.08.911.Peer-Reviewed Original ResearchRandomized trials of chemotherapyPhase II randomized trialECOG-ACRIN Cancer Research GroupTrials of chemotherapyCancer Research GroupOrgan preservationSurgery
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply